全文获取类型
收费全文 | 23836篇 |
免费 | 1230篇 |
国内免费 | 359篇 |
专业分类
耳鼻咽喉 | 85篇 |
儿科学 | 744篇 |
妇产科学 | 292篇 |
基础医学 | 1707篇 |
口腔科学 | 311篇 |
临床医学 | 2208篇 |
内科学 | 2600篇 |
皮肤病学 | 413篇 |
神经病学 | 265篇 |
特种医学 | 412篇 |
外国民族医学 | 291篇 |
外科学 | 1596篇 |
综合类 | 5854篇 |
现状与发展 | 1篇 |
预防医学 | 2140篇 |
眼科学 | 96篇 |
药学 | 3069篇 |
3篇 | |
中国医学 | 2326篇 |
肿瘤学 | 1012篇 |
出版年
2024年 | 7篇 |
2023年 | 81篇 |
2022年 | 154篇 |
2021年 | 258篇 |
2020年 | 211篇 |
2019年 | 229篇 |
2018年 | 333篇 |
2017年 | 239篇 |
2016年 | 275篇 |
2015年 | 310篇 |
2014年 | 4215篇 |
2013年 | 3028篇 |
2012年 | 2418篇 |
2011年 | 2151篇 |
2010年 | 3529篇 |
2009年 | 3204篇 |
2008年 | 1399篇 |
2007年 | 438篇 |
2006年 | 364篇 |
2005年 | 366篇 |
2004年 | 297篇 |
2003年 | 243篇 |
2002年 | 224篇 |
2001年 | 202篇 |
2000年 | 161篇 |
1999年 | 136篇 |
1998年 | 114篇 |
1997年 | 103篇 |
1996年 | 80篇 |
1995年 | 100篇 |
1994年 | 81篇 |
1993年 | 70篇 |
1992年 | 62篇 |
1991年 | 52篇 |
1990年 | 46篇 |
1989年 | 40篇 |
1988年 | 29篇 |
1987年 | 33篇 |
1986年 | 22篇 |
1985年 | 17篇 |
1984年 | 19篇 |
1983年 | 10篇 |
1982年 | 16篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 8篇 |
1978年 | 7篇 |
1977年 | 7篇 |
1976年 | 5篇 |
1974年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Angela Mauro Salvatore Mauro Roberto Rega Luigi Martemucci Rita Sottile 《Pediatric dermatology》2019,36(1):e34-e36
Henoch‐Schonlein purpura (HSP) is the most common systemic vasculitis in childhood. There is no consensus about the management for isolated cutaneous manifestations in HSP. We describe a case of HSP presenting with severe skin lesions that did not respond to standard therapy with corticosteroids. The 11‐year‐old child was treated with intravenous immunoglobulins, which induced rapid and persistent resolution of symptomatology. 相似文献
2.
《Paediatrics & Child Health》2019,29(8):339-344
Von Willebrand Disease is a common cause of excessive bruising and bleeding in children. This short article gives advice on diagnosis and management for paediatricians. Given its prevalence and presenting symptoms, VWD should always be considered in the assessment of children suspected of non-accidental injury. Its diagnosis can be challenging, not only because of the various subtypes of the disorder but because of the considerable overlap between VWD and normal individuals. Laboratory diagnosis requires a range of quantitative and qualitative tests of the VWF protein, with targeted gene analysis increasingly used to confirm the diagnosis of type 2 and type 3 VWD. Bleeding Assessment Tools may be helpful in directed laboratory testing but are often less so in young children who have had limited haemostatic challenges. Treatment for VWD includes the use of antifibrinolytic drugs, vasopressin or VWF-containing clotting factor concentrates. Treatment is often on-demand for individual bleeding episodes but there are specific indications for the use of prophylactic treatment in children. 相似文献
3.
4.
5.
M. KUWANA Y. KURATA† K. FUJIMURA‡ K. FUJISAWA§ H. WADA¶ T. NAGASAWA S. NOMURA†† T. KOJIMA‡‡ H. YAGI§§ Y. IKEDA 《Journal of thrombosis and haemostasis》2006,4(9):1936-1943
BACKGROUND: We proposed diagnostic criteria for immune thrombocytopenic purpura (ITP) by modifying the existing guidelines for diagnosis of ITP and by incorporating laboratory tests found useful for predicting its diagnosis, for example erythrocyte count, leukocyte count, anti-GPIIb/IIIa antibody-producing B cells, platelet-associated anti-GPIIb/IIIa antibodies, percentage of reticulated platelets, and plasma thrombopoietin. OBJECTIVE AND METHODS: To validate our criteria, we conducted a multi-center prospective study involving 112 patients with thrombocytopenia and a morphologically normal peripheral blood film at the first visit. Each patient underwent a physical examination, routine laboratory tests, and specialized tests for the anti-GPIIb/IIIa antibody response and platelet turnover. RESULTS: Ninety-one patients (81%) satisfied the proposed criteria at first visit. Clinical diagnosis was made by skilled hematologists > 6 months after the first visit; ITP was diagnosed in 88 patients and non-ITP disorders in 24. The proposed criteria had 98% sensitivity, 79% specificity, a 95% positive predictive value, and a 90% negative predictive value. A relatively low specificity appears to be attributed to a few patients who had both ITP and aplastic anemia or myelodysplastic syndrome. CONCLUSIONS: Our preliminary diagnostic criteria based on ITP-associated laboratory findings were useful for the differential diagnosis of ITP, but additional evaluations and modifications will be necessary to develop criteria that can be used routinely. 相似文献
6.
7.
8.
无国界医生致力于应对天灾和战祸所引起的人道医疗危机。灾后实时爆发的人道医疗危机包括急性的外科创伤问题和基础医疗系统的破坏导致疫症发生。本文介绍了无国界医生的救援经验以及专业的备灾体系。 相似文献
9.
左旋布比卡因复合舒芬太尼或芬太尼在分娩硬膜外自控镇痛的应用 总被引:1,自引:0,他引:1
目的探讨左旋布比卡因复合舒芬太尼硬膜外自控镇痛(PCEA)用于分娩镇痛的临床效果及安全性。方法随机选择120例美国标准协会(ASA)I-Ⅱ级初产妇,随机分为舒芬太尼组(A组)、芬太尼组(B组)、无镇痛组(C组),每组40例。A组和B组采用PCEA,C组不给予镇痛药物。观察各组不同时段视觉模拟评分(VAS)和不良反应的发生,同时记录3组产程时间、分娩方式、缩宫使用情况、产后出血量、新生儿Apgar评分。结果A、B2组和C组在PCEA20、60min及宫口开全时VAS差异有统计学意义(P〈0.05);PCEA5min,A、B2组VAS差异有统计学意义(P〈0.05),2组Bromage评分、不良反应差异无统计学意义(P〉0.05)。3组产程时间、分娩方式、产后出血量、新生儿Apgar评分比较差异均无统计学意义(P〉0.05)。结论左旋布比卡因复合舒芬太尼或芬太尼用于分娩镇痛安全有效,对母婴无明显不良影响。 相似文献
10.
Sundaram Hariharan Eric P. Cohen Brahm Vasudev Rimas Orentas Raphael P. Viscidi Justin Kakela Brian DuChateau 《American journal of transplantation》2005,5(11):2719-2724
We evaluated twenty renal transplant subjects at various stages of BKV nephritis (BKVN) for BKV-specific IgG and IgM antibodies using ELISA technique and BKV-DNA using PCR. They were divided as early onset (n = 7), stabilizing (n = 3), resolved (n = 8) and late onset (n = 2) BKVN. BKV-specific antibodies and BKV-DNA were simultaneously determined. The mean BKV-specific IgG level in early onset and stabilizing BKVN were 64 and 39 EIA units, and were significantly lower than 138 EIA units seen in resolved BKVN, P = 0.007, P = 0.008. The mean BKV-specific IgM levels in stabilizing BKVN was higher than resolved BKVN (130 vs 51 EIA units), P = 0.006. Mean plasma BKV loads for each group were 955,925, 5642 and 42 copies/mL of plasma, respectively. Prospective study in six BKVN cases revealed mean IgG, IgM levels and BKV-DNA at the time of diagnosis of BKVN as 39, 110 EIA units and 586,758 copies/mL of plasma, respectively. After a mean period of 5.2 months, IgG level increased to 120 EIA units (p = 0.0058) and had no detectable viral copies in circulation. Recovery from BKVN and elimination of BKV is associated with the development of BKV-specific IgG antibodies and this provides insight into the role of humoral immunity to BKV in the pathogenesis of BKVN. 相似文献